Speaker Profiles

Click the + buttons on the right of each box to view the bio for each speaker.

Keynote Speakers

HE. Dr. Hanan Mohamed Al Kuwari

Minister of Public Health in Qatar

President, Dr. Shaukat Sadikot

President Elect of the International Diabetes Federation

Dr. Jens-Christian Holm

Jens-Christian Holm, PhD is a Consultant in Pediatrics, Clinical and Research Associate Professor, and Head of The Childrens’ Obesity Clinic and The Danish Childhood Obesity Biobank, Department of Pediatrics, University Hospital Holbæk, Denmark.

Dr. Holm is the supervisor of 19 PhD MDs; twelve research year medical students and seven employed in various scientific programs, including global consortia studies. Altogether these initiatives have enabled the establishment of The Danish Childhood Obesity Biobank, which aims to help 5,000 overweight and obese children transition to a normal weight.

Dr. Holm has established dynamic and productive collaborations with internationally recognized senior researchers specialized in the evaluation of research of obese children. Examples of these efforts are the global consortiums entitled “TARGET”, “BIOCHILD” and “EGG”, where he collaborates closely with internationally regarded researchers located all over the world.

Mr. Mads Bo Larsen

Mr. Mads Bo Larsen is Novo Nordisk’s Corporate Vice President of Business Area Gulf, India and Egypt (BAGIE).

During his tenure with Novo Nordisk, he has worked in various functions, including as a General Manager in GCC countries and Turkey. He was also VP for BANE/BANS. Before joining BAGIE he was VP of BAAGI and responsible for 67 countries primarily spread over the continent of Africa.

Mr. Lewis Affleck

Mr. Lewis Affleck joined Maersk Oil in 2010 as Managing Director of Maersk Oil Qatar, with overall responsibility for the company’s activities operating Qatar’s largest offshore oil field, Al-Shaheen. Maersk Oil Qatar is one of the founding partners of Action on Diabetes, a major private-public partnership to tackle diabetes in Qatar.

Mr. Affleck’s work in the oil and gas industry spans 30 years, working with AMOCO, LASMO and BG Group in various technical and senior management positions in Aberdeen, the United States, Pakistan, Columbia and the United Kingdom.

Before joining Maersk Oil, Mr. Affleck was Managing Director UK Upstream and President of BG Kazakhstan – BG Group’s two largest assets. Within the UK he led the rationalisation and turnaround of BG’s upstream UK business. While functioning as President of BG Kazakhstan he led the complex technical, organisational and political issues associated with the super-giant Karachaganak field development.

Mr. Affleck holds a Civil Engineering degree from Edinburgh’s Heriot‐Watt University and is an active member of the Society of Petroleum Engineers (SPE).


Dr. Haifa Hamad Abdalla Fares

Dr. Haifa Hamad Abdalla Fares is a Consultant, Family Physician and Head of the Program Section, Primary Care Department, Ministry of Public Health, UAE. She is responsible for developing and implementing strategic plans for primary healthcare programs across the UAE, overseeing the management and coordination of health programs and evaluating those program’s results and outcomes.

Dr. Fares leads the National Periodic Health Screening Initiative (Etmnan), which aims to provide early detection of non-communicable diseases. She is a founding member and the Program Director of the Family Medicine Residency Program at the Ministry of Health.

Dr. Hadi Abderrehim

Dr. Samya Ahmad Al Abdulla

Dr. Samya Ahmad Al Abdulla is a Senior Consultant and Family Physician with a special interest in diabetes and chronic disease. She is the Project Lead for the implementation of the NCD National Strategy across Qatar’s primary healthcare sector. She led the operational implementation of NCD clinical guidelines for Type 2 diabetes, hypertension, asthma and dyslipidemia in NCD clinics. Additionally, she oversaw the roll out of the Qatar Diabetes Registry in ten Primary Health Care Corporation Health Centers, enabling standardized diabetes data sets to be captured from all participating diabetes patients.

She led the Project for Accountable Care (SMART Clinics) initiated at Al Wakra Health Center. This project is focused on the prevention of diabetes through early detection and disease management. The project will be extended to include other non-communicable diseases such as hypertension and bronchial asthma.

Dr. Al Abdulla is also the Project Lead for the Annual Health Checkup project, which is in its initial stage. In 2017, the PHCC Health Check Service will be implemented at all 27 Health Centers. The objective of this service is to integrate the current SMART Clinic approach to the screening and care planning arrangements for diabetic, pre-diabetic and at-risk patients.

Dr. Al Abdulla is a faculty member of the Family Medicine Residency program at Weill Cornell Medical College. She hold the managerial position of Executive Director of Operations at her clinic, the Airport Health Center, and is responsible for managing the Regional Directors of Operations and delivering necessary directions and support to provide uninterrupted services in the regional Health Centers. She oversees support process improvements, Health Center improvement projects and the development and implementation of relevant PHCC policies and procedures.

Prof. Juliana Chan

Professor Juliana Chan is a Professor of Medicine and Therapeutics, Director, Hong Kong Institute of Diabetes and Obesity, CUHK, Director, Diabetes Education and Professional Development Centre, CUHK, Director, Clinical Research Management Office, CUHK, Co-Director, CUHK-PWH International Diabetes Federation Centre of Education and Chief Executive Officer, Asia Diabetes Foundation.

She is a clinician scientist and graduate of The Liverpool University, UK. She holds accreditations in endocrinology and clinical pharmacology. Her areas of specialty include epidemiology, genetics, clinical trials and care models. Since joining The CUHK in 1989, she has built up a 60-member multidisciplinary team to discover, disseminate and apply knowledge in the field of diabetes and its co-morbidities in Chinese populations.

She has supervised 50 postgraduate students and scientists and co-authored over 330 peer reviewed articles and 20 book chapters. She is a member of the NIH-funded Global Consortium to discover diabetes genes, steering committees of multicentre outcome trials, and advisory boards for government and organizations, including the World Health Organization and the International Diabetes Federation (IDF), a global advocacy body for people with diabetes. Over the years, her team has set up a CUHK-affiliated multidisciplinary diabetes centre, a community-based nurse-led risk assessment centre and a charitable foundation to translate these discoveries into products/services to benefit the community.

In 2011, she received the China Women Physicians Association Intercontinental Innovative Award under the Chinese Ministry of Science and Technology. In 2011, the CUHK-PWH Diabetes and Endocrine Centre was selected as one of the 8 IDF Centres of Education for its excellence in professional education and innovative care models.

Dr. Anders Dejgaard

Dr. Anders Dejgaard is Managing Director of the World Diabetes Foundation. He is a physician by training and a certified specialist in endocrinology. He worked at the Steno Diabetes Centre for more than four years and has published more than 80 scientific articles, including a doctoral thesis on Diabetic Autonomic neuropathy. During his career, he has been a scientific reviewer for many different medical and endocrine journals and has given lectures all over the world.

In April 2013, he took over the position as Managing Director of the World Diabetes Foundation. His focus at the WDF has included the future strategic direction of the Foundation and defining clinical impact indicators of the programs that the Foundation is supporting.

Prior to this, he worked at Novo Nordisk A/S for more than 30 years in various managerial roles, lastly as Corporate Vice President in clinical research and drug development and Chief Medical Officer.

Dr. Dejgaard has a keen interest in diabetes prevention and program evaluation.

Dr. Abdulla Al-Hamaq

Dr. Abdulla Al-Hamaq is Executive Director of the Qatar Diabetes Association, Qatar Foundation for Education, Science and Community Development.

He was elected as the Regional Manager of the IDF/MENA Region on 2010. He was the President of Diabetes in Asia Study Group (DASG) until 2011. Dr. Al-Hamaq is a fellow of the Royal Society for Public Health (FRSPH), a member of the American Diabetes Association (ADA), a member of the European Association for the Study of Diabetes (EASD) and the American Association of Clinical Endocrinologists(AACE). He is also the General Secretary for the Gulf Group for the Study of Diabetes (GGSD).

Prof. Richard IG Holt

Professor Richard Holt trained at the University of Cambridge and the London Hospital Medical College. He is a Professor in Diabetes and Endocrinology at the University of Southampton and an Honorary Consultant Physician in Diabetes and Endocrinology at the University Hospital Southampton NHS Foundation Trust.

Professor Holt’s current research interests are broadly focused around clinical diabetes but specifically encompass studies of the relationship between mental illness and diabetes and, diabetes and pregnancy. His clinical responsibilities include the diabetes and pregnancy clinic, young adult diabetes clinic and the cystic fibrosis related diabetes service.

Professor Holt is the Editor-in-Chief of Diabetic Medicine and is the immediate past-Chair of the Council of Health Care Professionals of Diabetes UK. Professor Holt was a member of the 2008 NICE diabetes and pregnancy guideline development group and the NICE Type 2 diabetes Preventing the Progression from Pre-Diabetes Programme development group. Professor Holt is the Editor-in-Chief of the 4th edition of the Textbook of Diabetes.

Prof. Bjarne Brunn Jensen

Bjarne Bruun Jensen is a professor and director of Steno Health Promotion Research at Steno Diabetes Center in Gentofte, Denmark. The overall vision is to position Steno Health Promotion Research as an international leading center in Research and Development in the fields of patient education, prevention and health promotion.

Bjarne Bruun Jensen is Adjunct Professor at Aalborg University (Denmark) and Norwegian University of Science and Technology (Norway). He is one of the leading researchers in health promotion, including the concepts of salutogenesis, empowerment, health literacy and action competence.

Bjarne Bruun Jensen is involved as referee and in editorial boards at many international journals. He has published 29 books, 103 articles in journals, 94 chapters in books. He is editor of 31 books.

Previously Bjarne Bruun Jensen has been employed as a professor in health and environmental education at the Danish University of Education where he directed the research programme for Environmental and Health Education.

Dr. Ernest Massiah

The World Bank

Dr. Kholoud Al-Mutawa

Prof. David Napier

A. David Napier is Professor of Medical Anthropology at University College London (UCL) and Director of its Science, Medicine, and Society Network. He has been a fellow of a number of universities and colleges, including Harvard University, New York University, the Johns Hopkins University, All Souls College, Oxford, and Green Templeton College, Oxford. Napier’s special interests include assessing vulnerability, diabetes vulnerability, primary health-care delivery, human wellbeing, and migration. He has published widely in these areas and also on law and anthropology, and intellectual property and biodiversity, as well as being the author of many scholarly books and numerous book chapters. Napier has been involved in three Lancet commissions, leading the 2014 Lancet Commission on Culture and Health. His recent book, Making Things Better (Oxford University Press 2013) explores notions of property and local value across cultures. He regularly writes for the press (e.g., Le Monde) and his work and writing have been featured in The New York Times, The Financial Times, and The Guardian, among others. For his activities with more than 100 charities and NGOs, the UK government and research councils awarded him the first Beacon Fellowship in Public Engagement. He is also the recipient of the Burma Coalition’s Human Rights Award. Napier has served as a consultant on vulnerable populations in the aftermath of natural and human disasters, having worked for, among others, the World Health Organization, CRISIS UK, The United Nations, and the International Organization for Migration. He is currently the academic lead on a global Cities Changing Diabetes initiative with Novo Nordisk, Denmark and the Steno Diabetes Center, Copenhagen.

Ms. Manal Musallam Othman

Ms. Manal Musallam Othman is the Director of Diabetes Education at Hamad Medical Corporation. She is a Member of the Scientific Committee of the Qatar Diabetes Association and the Co- Chair of the National Patient Empowerment Committee. Ms. Othman is the Chair of the Qatar Metabolic Institute Education Committee and established Qatar's first Accredited Diabetes Education Course in collaboration with the College of the North Atlantic in Qatar. She is a main organizer of various national diabetes awareness campaigns and a regular speaker on national television and radio, addressing both diabetes and general public health topics. She is also an international lecturer in diabetes education.

Ms. Othman graduated from nursing school in Jordan in 1993 with a bachelors degree. In 2007 she completed her master in public health/community medicine. She has published three papers about diabetes prevalence and metabolic syndrome among the Qatari population in international journals.

Mr. Steve Phoenix

Steve Phoenix is Group Chief for General Hospitals at Hamad Medical Corporation, Qatar, responsible for three hospitals outside of Doha; Al Khor; Al Wakra and the Cuban Hospital. He is one of the members of HMC’s governing body, The Executive Management Committee. He is Chair of the Audit Committee; the HMC Diabetes Network and member of a number of other formal sub-committees, such as Finance & Resources. Steve has been involved with a number of Qatar national committees including Preventative & Public Health, Continuing Care and Diabetes.

Steve joined HMC in September 2011 after a 31 year career in the UK NHS. Most recently he was Chief Executive of NHS West Kent (2006-2011). Beyond the local role Steve had responsibility for planning and funding all acute hospital care in Kent & Medway (population 2.3m) and all specialist/tertiary care for south-east England (population 4.9m). In this role he managed a budget of around 9 billion riyals.

He was Chair of a number of bodies locally; the Kent & Medway Stroke Network; Kent & Medway Pathology Network; South East England Specialist Services Commissioning Board and of the Chief Executives `Alliance’ group for South East England. At a national level he was a member of the National Specialist Commissioning Board and was part of the review of Paediatric Cardiac Surgery in England.

In 2001 Steve became CEO of AAW Primary Care Trust. Between 1988 and 2001 he held a variety of Executive Board-level posts in Sussex health authorities including Director of HR and OD; Deputy Chief Executive; Director of Commissioning and Director of Performance.

Dr. Thenaa K. Said

Dr. Thenaa K. Said graduated from Baghdad University with a BSc in Pharmacy. She completed her MSc and PhD at Manchester Medical School, UK, followed by a postdoc at Christi Hospital in Manchester, UK. In 1980, Dr. Said was appointed Assistant Professor at Al-Mustansiryah Medical School in Baghdad, Iraq, and established her first research lab and received her first research grant from the WHO.

In 1991, Dr. Said completed a sabbatical year with the Department of Medical Oncology-Health Science and Technology Center, University of Texas, San Antonio, studying the signaling pathways of tyrosine phosphorylated proteins in different breast cancer tumor phenotypes. A year later, she joined the Department of Molecular and Cellular Biology at Baylor College of Medicine, Houston, Texas, where she was a faculty member until 2006. During this period, Dr. Said received research funds from NIH, DOD, Susan Komen Foundation, AACR and institutional funds. Throughout her professional career, Dr. Said has been involved in teaching medical students, supervising graduate students, and leading her own research projects. Dr. Said’s research focused on studying normal mammary gland development and tumorigenesis utilizing various mouse mammary models. Data from Dr. Said’s research were published in 23 peer-reviewed international journals of high-impact value. Dr. Said joined QNRF in 2006 as a Program Manager in the Biomedical and Health Pillar; she is currently a Director of the same pillar. She contributed significantly in the development of QNRF’s research funding programs, review process, research guidelines, policies and regulations. Dr. Said has contributed to several QNRF projects, including the development of the Qatar Biobank project, the Qatar Cancer Research Strategies and the Qatar National Research Strategy for health. She is a member of various QNRF steering committees, including the personalized medicine steering group. She is also a member of the Qatar metabolic syndromes working group and has ad hoc memberships with several other committees.

Prof. Franco Sassi

Franco Sassi holds a Chair in International Health Policy and Economics. Currently, he is also a Senior Health Economist at the Organisation for Economic Co-operation and Development (OECD, Paris), where he developed and was responsible for the Organisation's Public Health Programme. His work has been aimed at assessing the impacts of public policies to tackle major chronic diseases and their predisposing risk factors, including poor nutrition, physical inactivity, alcohol and tobacco use, and a range of environmental and social exposures. He is the author and editor of a large number of publications on economic aspects of public health, including the books “Obesity and the economics of prevention: Fit not fat”, in 2010, and "Tackling harmful alcohol use: Economics and public health policy" in 2015. Prior to joining the OECD, Franco was a senior lecturer in health policy at the London School of Economics and Political Science (LSE), and director of the graduate programme in Health Policy, Planning and Financing. Franco obtained his doctorate in health economics from the University of London. The overarching theme of his research and publications has been the evaluation of health interventions. He held an adjunct professor position at the Université de Montréal, as well as visiting positions at a number of universities in the United States, including University of California at Berkeley, Harvard University, University of California at San Francisco, and Duke University, and at the Catholic University of Rome. He was awarded a 2000-01 Harkness Fellowship in Health Care Policy by the Commonwealth Fund.

Mr. Egbert Schillings

Egbert Schillings was appointed Chief Executive Officer of WISH in April 2014. Mr Schillings is a seasoned business leader with 20 years' experience in the global healthcare industry, across payers, provider systems, best practice research, and consulting. As Chief Executive Officer, Mr Schillings is committed to leading the evolution of WISH to become a research-based but action-focused global community of like-minded leaders, all equally dedicated to improving healthcare globally through accelerating the innovation cycle for the benefit of populations everywhere.

Previously, he was SVP of Client Service for McKinsey’s Leading Systems Network, which convened health systems globally for collective performance improvement. He has deep expertise in performance improvement, leadership development, and communications in health care systems, as well as business development and client service.

Prior to joining McKinsey, Mr Schillings served as Managing Director at Kaiser Permanente in Oakland, California, the United States’ largest private integrated health care system. He was also a Senior Director at The Advisory Board Company, a provider of best practice research, business intelligence, education, and consulting services to the healthcare sector. In Washington, DC, he worked on public health and insurance industry legislation for The American Lung Association and for the Health Insurance Association of America (HIAA). Egbert also served as a legislative aide to the Honorable Lee H. Hamilton on the staff of the House International Relations Committee in the U.S. House of Representatives.

Mr Schillings received his degree at Freie Universität Berlin and was a Fulbright Scholar in Political Science at George Washington University in Washington, DC.

Dr. Khalid Al Rubeaan

Dr. Khalid Al Rubeaan is a Senior Endocrinologist and Associate Professor in Medicine at the College of Medicine, King Saud University, Riyadh, Saudi Arabia. He main areas of interest include endocrine diseases, especially diabetes mellitus. His main areas of research interest include basic research, education, prevention and the epidemiology of diabetes mellitus in Saudi Arabia and the Middle East.

Dr. Al Rubeaan is the Executive Director of the Strategic Center for Diabetes Research and Editor-in-Chief of the International Journal of Diabetes Mellitus. He is also Head of the Saudi National Diabetes Registry. He is a member of various associations and has numerous publications in the form of book chapters and scientific papers covering a variety of aspects of diabetes mellitus. His achievements include many national and international awards from government agencies as well as research and academic institutions. He also holds a patent in the field of Nano Technology and IT for the management of diabetes mellitus.

Prof. Abdul-Badi Abou-Samra

Dr. Abou-Samra is an academic MD/PhD physician scientist who is certified in internal medicine and in endocrinology by the American Board of Internal Medicine. Dr. Abou-Samra worked at several international institutions which include Lyon I University, France for five years, the National Institute of Health, Bethesda, Maryland for two years, Harvard Medical School and the Massachusetts General Hospital for 21 years, and the Wayne State University School of Medicine for five years. He was professor of medicine, professor of physiology, professor of molecular medicine and genetics, Chief of the Division of Endocrinology, Diabetes and Metabolic Diseases and Director of the clinical fellowship program in endocrinology and diabetes and of the endocrine research training program.

Dr. Abou-Samra received multiple recognitions for his scientific contributions and led several research projects funded by the National Institutes of Health. He is known for his molecular and clinical research on G protein-coupled receptors, insulin action and nutritionally-regulated genes. Dr. Abou-Samra published more than 140 original papers in peer-reviewed journals and contributed to 5 USA patents. He was member of NIH study section and member of editorial board for several international journals.

In January 2013 Dr. Abou-Samra joined Hamad Medical Corporation in Doha, Qatar, as the Chairman of the Department of Internal Medicine and Professor of Medicine at Weil Cornell Medical College - Qatar. Professor Abou-Samra is Co-Chair for the Qatar National Diabetes Committee with the mandate of developing a national strategy for diabetes in Qatar and Chairman for the Qatar Metabolic Institute.

Prof. Shahrad Taheri

Weil Cornell Medical College in Qatar

Dr. Al Anoud Mohammad Al-Thani

Dr. Al Anoud Mohammad Al-Thani graduated from Faculty of Medicine – Cairo University 2000. In 2008 she was the recipient of an Arab Fellowship in Community Medicine.

Dr. Al Anoud Al-Thani is a consultant in Public Health and is currently Manager of Health Promotion and Non-Communicable Diseases in the Public Health Department at Ministry Of Public Health. She is responsible for leading many National Programs and has headed number of national committees. She has chaired both the National Nutrition and Physical Activity Committee and National Diabetes Committee and is member in Midterm National Sport Strategy and National Screening Committee. She is also a focal point for non-communicable diseases, nutrition and physical activity at both level international level (WHO) and regional level (GCC) and represents the organization at many meeting and conferences.

During her tenure developed the department’s programs and its system to achieve to perform its functions more effectively and efficiently.

She has also participated in many research programs which have had a positive impact on public health programs in Qatar and the region.

Dr. Mohamed Al Thani

Sheikh Dr. Mohammed Al Thani has been the Director of Public Health Department in the Ministry of Health in the State of Qatar since 2008.

The Public Health Department is the largest Department in the Ministry of Public Health. It currently employs around 400 staff. It is divided into three departments and several sections and units.

The departments are:

  • Health promotion and non-communicable diseases
  • Health prevention and communicable diseases
  • Food safety and environmental health.

Dr. Mohamed developed programs to protect the health of individuals, families and community in Qatar. He placed a high priority in developing the first Public Health Strategy in Qatar, which will be implemented during 2016. He is continually conducting clinical research studies in the most ethical and safest manner possible to develop an integrated approach to health prevention and promotion.

Dr. Mohamed Al Thani has headed number of national committees including the National Preventive Health Committee, which aims to address the many facets of transitioning from a curative to a preventive health focus and to ensure a robust preventive health governance system is in place.

His other affiliations include:

  • Being Assistant Professor of Public Health in Weill Cornel Medical College ( Courtesy ),
  • Member of Qatar Executive Board
  • Member of the Executive Board of Health Ministers’ Council for GCC

Dr. Mohammed Al Thani graduated from the Faculty of Medicine – Cairo University in 1998. He completed his fellowship in Community Medicine in 2006.

He gained the Fellowship from the Faculty of Public Health in London in 2010 and obtained a Master in Business Administration in 2014 from HEC Paris - France (Ecole des Hautes Etudes Commercials de Paris) which is an European business school.

Herluf Nis Thomsen

Herluf Nis Thomsen was appointed to head up the Action on Diabetes program in Qatar after having successfully driven several key CSR and Public affairs initiatives in Novo Nordisk over the past 10 years. Herluf has been developing and implementing CSR related projects in many parts of the world including USA, China, Russia and the Middle East, in cooperation with global organizations such as International Diabetes Foundation, World Diabetes Federation, WHO and Local governments. He has a background in Global Marketing in Novo Nordisk and holds a Master degree in Public Administration and a M.A. in European Society, Science and technology (ESST).

Herluf is a member of the Qatar National Diabetes Commission.

Ms. Ingrid Willaing

Research in Patient Education and Patient Support is a long-standing interest for Ingrid. She has a background in Public Health Science and has wide experience in health promotion, prevention and rehabilitation in relation to chronic disease.

Ingrid has worked with prevention and rehabilitation together with municipalities and regions, NGOs, policy makers and researchers on a national and an international basis. Health Services Research and studies concerning health care professionals, patients and people at risk have been significant to her research over the years.

Her research activity is now focused on development of research based diabetes patient education methods and psychosocial support, family perspectives on diabetes and diabetes and work life with a specific focus on the user-driven development of interventions to enhance empowerment and quality of life with type 1 and type 2 diabetes as well as to prevent diabetes complications.


Ms. Silvia Fath

Silvia Fath is Director Strategic Operations in BAGIE (Gulf, India and Egypt) since May 2016. Silvia is a pharmacist by training and has more than 18 years of experience in life sciences managing sales, marketing, business development and commercial T&D.

Silvia joined Novo Nordisk in 2008, responsible for the strategic market entry of Victoza® in the Emerging Markets covering Latin America, Near and Far East, Russia/CIS and Africa and Gulf countries.

For the past four years Silvia has been overseeing commercial effectiveness in European countries and has been developing go to market models for new market entries. Prior to joining Novo Nordisk Silvia has gained experience in various marketing and sales management functions in MSD and Eli Lilly in Switzerland.

Mr. Graham Leach

Graham Leach has spent more than 30 years working in broadcast news, both studio presenting and reporting from around the world.

Graham was trapped in west Beirut for three months when the Israelis invaded in 1982. He witnessed the collapse of apartheid in South Africa. He was in East Berlin on the night the Wall came down in November 1989, passing through Checkpoint Charlie from east to west when the gates opened at midnight. He then reported on the collapse of the communist regimes in Czechoslovakia and Romania.

He also covered the European Union, including the many battles between British governments and Brussels. He has presented the flagship Today program on BBC Radio 4, the breakfast program on LBC and reported for the 24-hours news team at Sky News.